Owens & Minor, Inc. Stock

Equities

OMI

US6907321029

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
17.43 USD +1.04% Intraday chart for Owens & Minor, Inc. -0.57% -9.55%
Sales 2024 * 10.66B Sales 2025 * 10.96B Capitalization 1.33B
Net income 2024 * - Net income 2025 * 88M EV / Sales 2024 * 0.29 x
Net Debt 2024 * 1.76B Net Debt 2025 * 1.53B EV / Sales 2025 * 0.26 x
P/E ratio 2024 *
249 x
P/E ratio 2025 *
20.6 x
Employees 22,200
Yield 2024 *
0.02%
Yield 2025 *
0.02%
Free-Float 97.46%
More Fundamentals * Assessed data
Dynamic Chart
Owens & Minor, Inc. Names Jennifer Stone as Executive Vice President & Chief Human Resources Officer, Effective June 3, 2024 CI
Transcript : Owens & Minor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 02:20 PM
Owens & Minor, Inc. Names Snehashish Sarkar as Executive Vice President & Chief Information Officer CI
Transcript : Owens & Minor, Inc. - Shareholder/Analyst Call
Baird Adjusts Owens & Minor Price Target to $24 From $28, Maintains Neutral Rating MT
Owens & Minor Insider Sold Shares Worth $585,680, According to a Recent SEC Filing MT
Owens & Minor Q1 Adjusted Net Income, Revenue Increase; Maintains 2024 Guidance -- Shares Rise Pre-Bell MT
Transcript : Owens & Minor, Inc., Q1 2024 Earnings Call, May 03, 2024
Owens & Minor, Inc. Provides Earnings Guidance for the Year 2024 CI
Owens & Minor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (OMI) OWENS & MINOR Reports Q1 Revenue $2.61B, vs. Street Est of $2.61B MT
Earnings Flash (OMI) OWENS & MINOR Reports Q1 EPS $0.19, vs. Street Est of $0.18 MT
Owens & Minor, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Citigroup Adjusts Price Target on Owens & Minor to $28 From $24, Maintains Neutral Rating MT
Owens & Minor, Inc. Announces Retirement of Dan J. Starck as Executive Vice President, Business Excellence, Effective May 17, 2024 CI
More news
1 day+1.04%
1 week-0.57%
1 month-29.55%
3 months-28.36%
6 months-12.32%
Current year-9.55%
More quotes
1 week
16.91
Extreme 16.91
17.70
1 month
16.91
Extreme 16.91
24.55
Current year
16.91
Extreme 16.91
28.35
1 year
13.64
Extreme 13.64
28.35
3 years
11.79
Extreme 11.79
49.16
5 years
2.43
Extreme 2.43
49.16
10 years
2.43
Extreme 2.43
49.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 19-03-06
Director of Finance/CFO - 20-03-31
Chief Tech/Sci/R&D Officer 49 22-11-30
Members of the board TitleAgeSince
Chief Executive Officer 57 19-03-06
Director/Board Member 69 19-09-30
Director/Board Member 65 22-05-31
More insiders
Date Price Change Volume
24-05-31 17.43 +1.04% 709,006
24-05-30 17.25 -0.69% 486,524
24-05-29 17.37 +0.46% 364,389
24-05-28 17.29 -1.37% 794,195
24-05-24 17.53 +1.45% 448,511

Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT

More quotes
Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own proprietary products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. It also offers a variety of programs providing outsourced logistics and marketing solutions to its suppliers as well. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and a provider of integrated home healthcare equipment and related services.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
17.43 USD
Average target price
22.57 USD
Spread / Average Target
+29.50%
Consensus